{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:15:33Z","timestamp":1781658933584,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Plus disease is characterized by abnormal changes in retinal vasculature of premature infants. Presence of Plus disease is an important criterion for identifying treatment-requiring cases in Retinopathy of Prematurity (ROP). However, diagnosis of Plus disease has been shown to be subjective and there is wide variability in the classification of Plus disease by ROP experts, which is mainly because experts have different cut-points for distinguishing the levels of vascular abnormality. This suggests that a continuous Plus disease severity score may reflect more accurately the behavior of expert clinicians and may better standardize the classification. The effect of using quantitative methods and computer-based image analysis to improve the objectivity of Plus disease diagnosis have been well established. Nevertheless, the current methods are based on categorical classifications of the disease severity and lack the compatibility with the continuous nature of the abnormal changes in retinal vasculatures. In this study, we developed a computer-based method that performs a quantitative analysis of vascular characteristics associated with Plus disease and utilizes them to build a regression model that outputs a continuous spectrum of Plus severity. We evaluated the proposed method against the consensus diagnosis made by four ROP experts on 76 posterior ROP images. The findings of our study indicate that our approach demonstrated a relatively acceptable level of accuracy in evaluating the severity of Plus disease, which is comparable to the diagnostic abilities of experts.<\/jats:p>","DOI":"10.1186\/s40942-025-00668-3","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T06:46:56Z","timestamp":1744354016000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SmartPlus: a computer-based image analysis method to predict continuous-valued vascular abnormality index in Retinopathy of Prematurity"],"prefix":"10.1186","volume":"11","author":[{"given":"Sayed Mehran","family":"Sharafi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Ebrahimiadib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramak","family":"Roohipourmoallai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsar","family":"Dastjani Farahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Imani Fooladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golnaz","family":"Gharehbaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8123-4375","authenticated-orcid":false,"given":"Elias","family":"Khalili Pour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"668_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","volume":"84","author":"C Gilbert","year":"2008","unstructured":"Gilbert C. Retinopathy of prematurity: A global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev. 2008;84:77\u201382.","journal-title":"Early Hum Dev"},{"key":"668_CR2","first-page":"730","volume":"112","author":"A Stahl","year":"2015","unstructured":"Stahl A, G\u00f6pel W. Screening and treatment in retinopathy of prematurity. Dtsch Arztebl Int. 2015;112:730\u20135.","journal-title":"Dtsch Arztebl Int"},{"key":"668_CR3","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1001\/jamaophthalmol.2014.84","volume":"132","author":"A Sommer","year":"2014","unstructured":"Sommer A, et al. Challenges of ophthalmic care in the developing world. JAMA Ophthalmol. 2014;132:640\u20134.","journal-title":"JAMA Ophthalmol"},{"key":"668_CR4","doi-asserted-by":"publisher","first-page":"e0219934","DOI":"10.1371\/journal.pone.0219934","volume":"14","author":"JW Chang","year":"2019","unstructured":"Chang JW. Risk factor analysis for the development and progression of retinopathy of prematurity. PLoS ONE. 2019;14:e0219934.","journal-title":"PLoS ONE"},{"key":"668_CR5","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.4103\/jfmpc.jfmpc_110_20","volume":"9","author":"SS Senjam","year":"2020","unstructured":"Senjam SS, Chandra P. Retinopathy of prematurity: addressing the emerging burden in developing countries. J Family Med Prim Care. 2020;9:2600\u20135.","journal-title":"J Family Med Prim Care"},{"key":"668_CR6","doi-asserted-by":"crossref","unstructured":"Global. regional and national burden of retinopathy of prematurity among childhood and adolescent: a spatiotemporal analysis based on the Global Burden of Disease Study 2019| BMJ Paediatrics Open. https:\/\/bmjpaedsopen.bmj.com\/content\/8\/1\/e002267","DOI":"10.1136\/bmjpo-2023-002267"},{"key":"668_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/archopht.1988.01060130517027","volume":"106","author":"Multicenter Trial of Cryotherapy for Retinopathy of Prematurity","year":"1988","unstructured":"Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. Preliminary results. Arch Ophthalmol. 1988;106:471.","journal-title":"Arch Ophthalmol"},{"key":"668_CR8","first-page":"233","volume":"102","author":"WV Good","year":"2004","unstructured":"Good WV, Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc. 2004;102:233\u201348. discussion 248\u2013250.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"668_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"HA Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner HA, Kennedy KA, Chuang AZ, BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3\u2009+\u2009retinopathy of prematurity. N Engl J Med. 2011;364:603\u201315.","journal-title":"N Engl J Med"},{"key":"668_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/archopht.125.7.875","volume":"125","author":"MF Chiang","year":"2007","unstructured":"Chiang MF, Jiang L, Gelman R, Du YE, Flynn JT. Interexpert agreement of plus disease diagnosis in retinopathy of prematurity. Arch Ophthalmol. 2007;125:875\u201380.","journal-title":"Arch Ophthalmol"},{"key":"668_CR11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1001\/jamaophthalmol.2016.0611","volume":"134","author":"JP Campbell","year":"2016","unstructured":"Campbell JP, et al. Expert diagnosis of plus disease in retinopathy of prematurity from Computer-Based image analysis. JAMA Ophthalmol. 2016;134:651\u20137.","journal-title":"JAMA Ophthalmol"},{"key":"668_CR12","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1016\/j.ophtha.2016.07.020","volume":"123","author":"J Kalpathy-Cramer","year":"2016","unstructured":"Kalpathy-Cramer J, et al. Plus disease in retinopathy of prematurity: improving diagnosis by ranking disease severity and using quantitative image analysis. Ophthalmology. 2016;123:2345\u201351.","journal-title":"Ophthalmology"},{"key":"668_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cmpb.2015.06.004","volume":"122","author":"V Bol\u00f3n-Canedo","year":"2015","unstructured":"Bol\u00f3n-Canedo V, et al. Dealing with inter-expert variability in retinopathy of prematurity: a machine learning approach. Comput Methods Programs Biomed. 2015;122:1.","journal-title":"Comput Methods Programs Biomed"},{"key":"668_CR14","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/j.ophtha.2016.07.026","volume":"123","author":"JP Campbell","year":"2016","unstructured":"Campbell JP, et al. Plus disease in retinopathy of prematurity: A continuous spectrum of vascular abnormality as a basis of diagnostic variability. Ophthalmology. 2016;123:2338\u201344.","journal-title":"Ophthalmology"},{"key":"668_CR15","first-page":"4757","volume":"60","author":"SJ Kim","year":"2019","unstructured":"Kim SJ, et al. A proposed 1 to 9 severity scale for vascular abnormalities in retinopathy of prematurity. Investig Ophthalmol Vis Sci. 2019;60:4757.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"668_CR16","first-page":"178","volume":"8","author":"N Valikodath","year":"2019","unstructured":"Valikodath N, Cole E, Chiang MF, Campbell JP, Chan R. V. P. Imaging in retinopathy of prematurity. Asia Pac J Ophthalmol (Phila). 2019;8:178\u201386.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"668_CR17","doi-asserted-by":"publisher","first-page":"812","DOI":"10.4103\/ijo.IJO_1917_20","volume":"69","author":"K Agarwal","year":"2021","unstructured":"Agarwal K, et al. Imaging the pediatric retina: an overview. Indian J Ophthalmol. 2021;69:812.","journal-title":"Indian J Ophthalmol"},{"key":"668_CR18","doi-asserted-by":"publisher","unstructured":"Ronneberger O, Fischer P, Brox T. U-Net: Convolutional Networks for Biomedical Image Segmentation. Preprint at https:\/\/doi.org\/10.48550\/arXiv.1505.04597 (2015).","DOI":"10.48550\/arXiv.1505.04597"},{"key":"668_CR19","volume-title":"Investigation of the retinal biomarkers of Alzheimer\u2019s disease and atherosclerosis using hyperspectral images","author":"Sayed Mehran Sharafi","year":"2019","unstructured":"Sayed Mehran Sharafi. Investigation of the retinal biomarkers of Alzheimer\u2019s disease and atherosclerosis using hyperspectral images. Montreal, Canada: Ecole Polythechnique at University of Montreal; 2019."},{"key":"668_CR20","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.1706.05721","author":"SSM Salehi","year":"2017","unstructured":"Salehi SSM, Erdogmus D, Gholipour A. Tversky loss function for image segmentation using 3D fully convolutional deep networks. Preprint at. 2017. https:\/\/doi.org\/10.48550\/arXiv.1706.05721.","journal-title":"Preprint at"},{"key":"668_CR21","unstructured":"Chiang MF et al. International Classification of Retinopathy of Prematurity, Third Edition. Ophthalmology 128, e51\u2013e68 (2021)."},{"key":"668_CR22","unstructured":"Patasius M, Marozas V, Lukosevicius A, Jegelevicius D. Evaluation of tortuosity of eye blood vessels using the integral of square of derivative of curvature. 3rd European Medical & Biological Engineering Conference, IFMBE European Conference on Biomedical Engineering EMBEC\u00b405, November 20-25, 2005, Prague, Czech Republic \/ Kneppo, P. & Hozman, J. (Eds.)., 2005;11(1):2005, https:\/\/hdl.handle.net\/20.500.12512\/79298."},{"key":"668_CR23","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41598-022-04796-w","volume":"12","author":"V Kashyap","year":"2022","unstructured":"Kashyap V, et al. Accuracy of vascular tortuosity measures using computational modelling. Sci Rep. 2022;12:865.","journal-title":"Sci Rep"},{"key":"668_CR24","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.1038\/s41598-024-57072-4","volume":"14","author":"SM Sharafi","year":"2024","unstructured":"Sharafi SM, et al. Automated diagnosis of plus disease in retinopathy of prematurity using quantification of vessels characteristics. Sci Rep. 2024;14:6375.","journal-title":"Sci Rep"},{"key":"668_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/tvst.4.6.5","volume":"4","author":"E Ataer-Cansizoglu","year":"2015","unstructured":"Ataer-Cansizoglu E, et al. Computer-Based image analysis for plus disease diagnosis in retinopathy of prematurity: performance of the i-ROP system and image features associated with expert diagnosis. Trans Vis Sci Tech. 2015;4:5.","journal-title":"Trans Vis Sci Tech"},{"key":"668_CR26","first-page":"614","volume":"18","author":"W Li","year":"2019","unstructured":"Li W, et al. Soluble Tei2 fusion protein inhibits retinopathy of prematurity occurrence via regulation of the Ang\/Tie2 pathway. Experimental Therapeutic Med. 2019;18:614\u201320.","journal-title":"Experimental Therapeutic Med"},{"key":"668_CR27","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1111\/aos.14264","volume":"98","author":"J Mao","year":"2020","unstructured":"Mao J, et al. Automated diagnosis and quantitative analysis of plus disease in retinopathy of prematurity based on deep convolutional neural networks. Acta Ophthalmol. 2020;98:e339\u201345.","journal-title":"Acta Ophthalmol"},{"key":"668_CR28","doi-asserted-by":"crossref","unstructured":"A C, W, H., M, J., D, B., J C-K. Morphology and vessel density of the macula in preterm children using optical coherence tomography angiography. J Clin Med 11, (2022).","DOI":"10.3390\/jcm11051337"},{"key":"668_CR29","first-page":"161","volume":"7","author":"W Yang","year":"2012","unstructured":"Yang W, Wang K, Zuo W. Neighborhood component feature selection for High-Dimensional data. JCP. 2012;7:161\u20138.","journal-title":"JCP"},{"key":"668_CR30","doi-asserted-by":"publisher","first-page":"e2251512","DOI":"10.1001\/jamanetworkopen.2022.51512","volume":"6","author":"SK Eilts","year":"2023","unstructured":"Eilts SK, et al. Assessment of retinopathy of prematurity regression and reactivation using an artificial Intelligence-Based vascular severity score. JAMA Netw Open. 2023;6:e2251512.","journal-title":"JAMA Netw Open"},{"key":"668_CR31","doi-asserted-by":"crossref","unstructured":"Dk W, Z Z, Sf F. A pilot study using \u2018roptool\u2019 to quantify plus disease in retinopathy of prematurity. J AAPOS: Official Publication Am Association Pediatr Ophthalmol Strabismus 11, (2007).","DOI":"10.1016\/j.jaapos.2007.04.008"},{"key":"668_CR32","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1001\/archophthalmol.2010.133","volume":"128","author":"AE Kiely","year":"2010","unstructured":"Kiely AE, Wallace DK, Freedman SF, Zhao Z. Computer-assisted measurement of retinal vascular width and tortuosity in retinopathy of prematurity. Arch Ophthalmol. 2010;128:847\u201352.","journal-title":"Arch Ophthalmol"},{"key":"668_CR33","doi-asserted-by":"publisher","unstructured":"Tian P et al. Toward a severity index for ROP: 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC. 2016. 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2016 1312\u20131315 (2016) https:\/\/doi.org\/10.1109\/EMBC.2016.7590948","DOI":"10.1109\/EMBC.2016.7590948"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00668-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-025-00668-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00668-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T06:47:01Z","timestamp":1744354021000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-025-00668-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["668"],"URL":"https:\/\/doi.org\/10.1186\/s40942-025-00668-3","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"1 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}